tiprankstipranks
Trending News
More News >

Barinthus CSO Nadege Pelletier to depart, Geoffrey Lynn to succeed

Barinthus Biotherapeutics (BRNS) announced the promotion of Geoffrey Lynn to chief scientific officer, or CSO, effective as of December 1. Lynn succeeds Nadege Pelletier, who decided to pursue alternative opportunities closer to home after having served as Barinthus Bio’s CSO since early 2023.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue